Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-25-033472
Filing Date
2025-04-21
Accepted
2025-04-21 07:57:23
Documents
1
Period of Report
2025-04-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 4367
  Complete submission text file 0001213900-25-033472.txt   5914
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Issuer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MELINTA THERAPEUTICS, INC. 300 TRISTATE INTERNATIONAL, SUITE 272 LINCOLNSHIRE IL 60069
Business Address
Blum Susan (Reporting) CIK: 0001792253 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38762 | Film No.: 25851322